Moneycontrol PRO
HomeNewsOpinionHow Erez Israeli revived Dr Reddy’s by focusing on costs and non-US markets

How Erez Israeli revived Dr Reddy’s by focusing on costs and non-US markets

Erez Israeli who took over as chief executive officer of DRL in 2019 sharpened its focus on costs and execution. Its recovery holds a lesson or two for major drug firms

July 08, 2021 / 09:17 IST
How Erez Israeli revived Dr Reddy’s by focusing on costs and non-US markets

Representative image

Unlock This Article

Are you a PRO subscriber? Sign In

What Do You Get

  • Ad free Experience

    Seamless navigation, faster responses.

  • Expert Perspective

    Explore 230+ exclusive editorials every month

  • +

    Uncover Insights from World-Renowned Experts and Journalists

  • Actionable Insights

    40+ weekly investment ideas + 3 to 4 daily technical calls

  • Virtual Events

    Exclusive Live Webinars for Expert Trading & Investment Strategies!

  • Newsletters

    Stay ahead with daily and weekly insights

Unlock exclusive discounts